Success Study of Vasthyamayanthakam ghrutham in the Management of Grade 2 Prostatomegaly: A Case Report
Abstract
BPH is a common condition in older men causing bothersome lower urinary tract symptoms (LUTS) such as frequent urination, urgency, nocturia, intermittent weak force of stream, and the sensation of incomplete bladder emptying, usually seen after 5th decade of life. In Ayurveda, the two broad categories - Mutrakrichha and Mutraghata have been used to list all urinary diseases. BPH closely resembles with Vatashtheela disease in its sign and symptoms. It is manifested due to improper function of Apana Vayu along with the vitiation of Kapha and Pitta dosha. While minimally invasive surgical procedures are available for BPH, medical treatments are preferred as initial approach. The rational of the study aimed to evaluate the efficacy of unique Ayurvedic treatment for BPH in a short duration. In this case study, a case of Benign Prostatic Hyperplasia diagnosed with grade 2 prostatomegaly on Ultrasonography having LUTS was treated with Vasthyamayanthakam ghrutham using Avapeedaka Snehpana Method for 48 days (one mandala) along with 2 years in follow-up period. After completion of the treatment, changes in the subjective criteria by IPSS (International Prostate Symptoms Score) and changes in the objective criteria (by USG) were recorded. Finally, the study concluded that given treatment is found to be highly effective in the management of Benign Prostate Hyperplasia (BPH).
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions
- The Efficacy of Flogofilm® in the Treatment of Chronic Bacterial Prostatitis as an Adjuvant to Antibiotic Therapy: A Randomized Prospective Trial
- Inhibition of growth and contraction in human prostate stromal cells by silencing of NUAK1 and -2, and by the presumed NUAK inhibitors HTH01-015 and WZ4003
- Effectiveness and Safety of a New Nutrient Fixed Combination Containing Pollen Extract Plus Teupolioside, in the Management of LUTS in Patients with Benign Prostatic Hypertrophy: A Pilot Study
- Extract from Cucurbita pepo improves BPH symptoms without affecting sexual function: a 24-month noninterventional study
- Aquablation vs. holmium laser enucleation of the prostate for benign prostatic hyperplasia: a 150-patients prospective comparative multicenter study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.